EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSTRUG00000002962
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSTRUG00000021655
Gene Symbol: LOC101075152
4 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype

Ensembl ID : ENSTRUG00000028946
Gene Symbol: LOC101076344
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSTRUG00000015663
Gene Symbol: LOC101070091
3 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSTRUG00000017638
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin F2-Alpha Receptor

Ensembl ID : ENSTRUG00000007446
Gene Symbol: LOC101076066
3 Cross references
167 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSTRUG00000011708
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSTRUG00000016689
Gene Symbol: PTGS1
3 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSTRUG00000018069
Gene Symbol: PTGS1
3 Cross references
182 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSTRUG00000004240
Gene Symbol: PTGS2
3 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSTRUG00000008890
Gene Symbol: PSMA1
4 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSTRUG00000008340
Gene Symbol: PSMA3
4 Cross references
238 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).